Skin Clinical Trials
Narrow List by Age:
(Refer to Clinical Summary for age requirements)
Skin
| Protocol | Alliance A091903 |
|---|---|
| Cancer Type: | RESECTED MUCOSAL MELANOMA |
| Fast Facts |
A RANDOMIZED PHASE II TRIAL OF ADJUVANT NIVOLUMAB WITH OR WITHOUT CABOZANTINIB IN PATIENTS WITH RESECTED MUCOSAL MELANOMA
| Protocol | SWOG S2101 |
|---|---|
| Cancer Type: | melanoma |
| Fast Facts |
S2101: Biomarker Stratified CaboZantinib (NSC#761968) and NivOlumab (NSC#748726) (BiCaZO) - A Phase II Study of Combining Cabozantinib and Nivolumab in Participants with Advanced Solid Tumors (IO Refractory Melanoma or HNSCC) Stratified by Tumor Biomarkers - an immunoMATCH Pilot Study.
| Protocol | ECOG EA6244 |
|---|---|
| Cancer Type: | Skin-Melanoma |
| Fast Facts |
EA6244 - Randomized Phase III Study of Management of Treatment Naive Primary Melanoma in Elderly Patients
Please check out the rare protocol list to locate other studies within this disease site.
Please check out the rare protocol list to locate other studies within this disease site.
Cancer clinical trials are research studies for developing better ways of detecting,
treating, and eventually preventing cancer. By taking part in a clinical trial,
you are among the first to receive new research treatments before they are widely
available. Your participation in a clinical trial will influence the future direction
of cancer care.
If you are interested in participating in a clinical trial, consult with your physician.
Please note: clinical trials are not risk free. Patients must explore the options
that are best for their individuals needs with the help of their physician.
